Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 33, 2011 - Issue 4
33
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Granulocyte-colony stimulating factor protects memory impairment in the senescence-accelerated mouse (SAM)-P10

, , , , , , , , , & show all
Pages 354-359 | Published online: 19 Jul 2013

References

  • Burns A, Byrne EJ, Maurer K. Alzheimer's disease. Lancet 2002; 360: 163–65.
  • Weggen S, Rogers M, Eriksen J. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol Sci 2007; 28: 536–43.
  • Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006; 443: 796–802.
  • Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312–16.
  • Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, et al. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol 2001; 101: 305–10.
  • Dickson DW. Apoptotic mechanisms in Alzheimer neurofi-brillary degeneration: cause or effect? J Clin Invest 2004; 114: 23–27.
  • Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673–82.
  • Uberti D, Cantarella G, Facchetti F, Cafici A, Grasso G, Bemardini R, et al. TRAIL is expressed in the brain cells of Alzheimer's disease patients. Neuroreport 2004; 15: 579–81.
  • Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791–808.
  • Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005; 115: 2083–98.
  • Solaroglu I, Cahill J, Jadhav V, Zhang JH. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 2006; 37: 1123–28.
  • Jung KH, Chu K, Lee ST, Kang L, Kim SU, Kim M, et al. G-CSF protects human cerebral hybrid neurons against in vitro ischemia. Neurosci Lett 2006; 394: 168–73.
  • Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, Fukuda K, et al. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 2006; 113: 701–10.
  • Solaroglu I, Tsubokawa T, Cahill J, Zhang JH. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006; 143: 965–74.
  • Yata K, Matchett GA, Tsubokawa T, Tang J, Kanamaru K, Zhang JH, et al. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res 2007; 1145: 227–38.
  • Okuma Y, Murayama T, Tha KK, Yamada C, Hosokawa M, Ishikawa A, et al. Learning deficiency and alterations in acetylcholine receptors and protein kinase C in the brain of senescence-accelerated mouse (SAM)-P10. Mech Ageing Dev 2000; 114: 191–99.
  • Tsai KJ, Tsai YC, Shen CK. G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med 2007; 204: 1273–80.
  • Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47–60.
  • Clarke MS, Prendergast MA, Terry AV Jr. Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats. Learn Mem 1999; 6: 634–49.
  • Miyamoto M. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp Gerontol 1997; 32: 139–48.
  • Okuma Y, Murayama T, Tha KK, Yamada C, Hosokawa M, Ishikawa A, et al. Learning deficiency and alterations in acetylcholine receptors and protein kinase C in the brain of senescence-accelerated mouse (SAM)-P10. Mech Ageing Dev 2000; 114: 191–99.
  • Deigner HP, Haberkorn U, Kinscherf R. Apoptosis modulators in the therapy of neurodegenerative diseases. Expert Opin Investig Drugs 2000; 9: 747–64.
  • Cantarella G, Uberti D, Carsana T, Lombardo G, Bemardini R, Memo M. Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity. Cell Death Differ 2003; 10: 134–41.
  • Volmar CH, Ait-Ghezala G, Frieling J, Paris D, Mullan MJ. The granulocyte macrophage colony stimulating factor (GM-CSF) regulates amyloid beta (Abeta) production. Cytokine 2008; 42: 336–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.